UBC LATE STAGE (UK) LIMITED
Get an alert when UBC LATE STAGE (UK) LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-01-01 (in 8mo)
Last made up 2025-12-18
Watchouts
None on the register
Cash
£178K
+43.6% highest in 3 filed years
Net assets
£6M
+8.7% highest in 3 filed years
Employees
86
+17.8% highest in 3 filed years
Profit before tax
£633K
+26.6% highest in 3 filed years
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · latest reflected 2024-12-31
| Metric | Trend | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|
| Turnover | — | £7,850,478 | £9,941,894 | |
| Operating profit | — | £373,832 | £473,424 | |
| Profit before tax | £424,461 | £500,075 | £633,299 | |
| Net profit | £304,331 | £331,995 | £461,159 | |
| Cash | £106,834 | £124,094 | £178,223 | |
| Total assets less current liabilities | £5,005,495 | £5,333,284 | £5,793,112 | |
| Net assets | £4,959,560 | £5,291,555 | £5,752,714 | |
| Equity | £4,959,560 | £5,291,555 | £5,752,714 | |
| Average employees | 58 | 73 | 86 | |
| Wages | — | £4,409,924 | £7,248,848 | |
| Directors' remuneration | — | — | — |
Figures converted to GBP from USD at 0.748 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+26.6%
£7,850,478 £9,941,894
-
Cash
+43.6%
£124,094 £178,223
highest in 3 filed years
-
Net assets
+8.7%
£5,291,555 £5,752,714
highest in 3 filed years
-
Employees
+17.8%
73 86
highest in 3 filed years
-
Operating profit
+26.6%
£373,832 £473,424
-
Profit before tax
+26.6%
£500,075 £633,299
highest in 3 filed years
-
Wages
+64.4%
£4,409,924 £7,248,848
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|
| Operating margin | — | 4.8% | 4.8% | |
| Net margin | — | 4.2% | 4.6% | |
| Return on capital employed | — | 7.0% | 8.2% | |
| Current ratio | — | 4.09x | 3.94x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Moore Kingston Smith LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The intermediate parent company, ACP Ulysses Holdings Inc, have commited to continue providing financial support to meet the company's working capital requirements for a period of at least one year from the date of approval of the financial statements, and has also confirmed that they will not call in amounts owed to the group by the company for at least that period. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.”
Group structure
- UBC LATE STAGE (UK) LIMITED · parent
- United BioSource (Italy) S.R.L 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 14 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BIRD & BIRD COMPANY SECRETARIES LIMITED | Corporate Secretary | 2020-01-24 | — | — |
| BROWN, Rebeka Bracken | Director | 2023-01-01 | Jun 1975 | American |
| HARATZ, Michael Scott | Director | 2023-01-01 | Aug 1960 | American |
| TURNER, Karen Dickerson | Director | 2023-01-01 | Mar 1968 | American |
Show 14 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| MARIANO, John Baptiste | Secretary | 2008-12-18 | 2011-12-22 |
| AKISTER, John Edward | Director | 2008-12-18 | 2011-12-22 |
| BODMER, Kenneth John | Director | 2011-12-22 | 2013-02-01 |
| CLEIN, Mark Paul | Director | 2008-12-18 | 2011-12-22 |
| HAMEL, Richard Paul | Director | 2020-02-19 | 2023-01-01 |
| HART, Sean Lee | Director | 2011-12-22 | 2013-03-25 |
| HOUSTON, Christine | Director | 2016-03-15 | 2017-12-27 |
| LINDSAY, Patrick | Director | 2017-12-27 | 2023-01-01 |
| MARIANO, John Baptiste | Director | 2011-08-16 | 2011-12-22 |
| NORTON, David Allen | Director | 2013-02-01 | 2016-03-15 |
| RAMAGE, Jeffrey Michael | Director | 2020-02-19 | 2021-02-11 |
| SHIH, Arthur | Director | 2011-12-22 | 2012-08-15 |
| SLUSSER, Eric | Director | 2016-03-15 | 2017-10-25 |
| SOHAL, Jess | Director | 2017-12-27 | 2019-08-06 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| United Biosource Holding (Uk) Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 86 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-16 | CH01 | officers | Change person director company with change date | |
| 2025-12-31 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-08-27 | AA | accounts | Accounts with accounts type full | |
| 2025-04-11 | CH01 | officers | Change person director company with change date | |
| 2024-12-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-12-04 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-12-04 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-10-07 | AUD | auditors | Auditors resignation company | |
| 2024-10-02 | AA | accounts | Accounts with accounts type full | |
| 2024-01-12 | AA | accounts | Accounts with accounts type full | |
| 2023-12-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-01-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-01-18 | TM01 | officers | Termination director company with name termination date | |
| 2023-01-18 | TM01 | officers | Termination director company with name termination date | |
| 2023-01-18 | AP01 | officers | Appoint person director company with name date | |
| 2023-01-18 | AP01 | officers | Appoint person director company with name date | |
| 2023-01-18 | AP01 | officers | Appoint person director company with name date | |
| 2023-01-06 | AA | accounts | Accounts with accounts type full | |
| 2022-04-01 | TM01 | officers | Termination director company with name termination date | |
| 2022-01-07 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.